Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?

Autor: Wang-Lopez, Qian, Chalabi, Nassera, Abrial, Catherine, Radosevic-Robin, Nina, Durando, Xavier, Mouret-Reynier, Marie-Ange, Benmammar, Kheir-Eddine, Kullab, Sharif, Bahadoor, Mohun, Chollet, Philippe, Penault-Llorca, Frédérique, Nabholtz, Jean-Marc
Zdroj: In Critical Reviews in Oncology / Hematology July 2015 95(1):88-104
Databáze: ScienceDirect
Externí odkaz: